[HTML][HTML] The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) …
MG Shlipak, SL Tummalapalli, LE Boulware… - Kidney international, 2021 - Elsevier
Chronic kidney disease (CKD) causes substantial global morbidity and increases
cardiovascular and all-cause mortality. Unlike other chronic diseases with established …
cardiovascular and all-cause mortality. Unlike other chronic diseases with established …
[HTML][HTML] The role of opioids in pain management in elderly patients with chronic kidney disease: a review article
S Dolati, F Tarighat, F Pashazadeh… - … and Pain Medicine, 2020 - ncbi.nlm.nih.gov
Chronic kidney disease (CKD) is a global public health problem. Pain is one of the most
generally experienced symptoms by CKD patients. Pain management is a key clinical …
generally experienced symptoms by CKD patients. Pain management is a key clinical …
[HTML][HTML] Analgesic use and associated adverse events in patients with chronic kidney disease: a systematic review and meta-analysis
E Lambourg, L Colvin, G Guthrie, H Walker… - British Journal of …, 2022 - Elsevier
Background Treating pain in the context of chronic kidney disease (CKD) is challenging
because of altered pharmacokinetics and pharmacodynamics, with an increased risk of …
because of altered pharmacokinetics and pharmacodynamics, with an increased risk of …
[HTML][HTML] Association of Opioids and Nonsteroidal Anti-inflammatoryáDrugs With Outcomes in CKD: áFindings From the CRIC (Chronic Renal Insufficiency Cohort) …
Rationale & Objective Safe analgesic choices are limited in chronic kidney disease (CKD).
We conducted a comparative analysis of harm from opioids versus nonsteroidal anti …
We conducted a comparative analysis of harm from opioids versus nonsteroidal anti …
Associations of opioid prescriptions with death and hospitalization across the spectrum of estimated GFR
TK Novick, A Surapaneni, JI Shin… - Clinical Journal of the …, 2019 - journals.lww.com
Results The propensity-matched cohort included 46,246 patients prescribed either opioids
or NSAIDs between 2008 and 2017 (mean [SD] age, 54 [16] years; 56% female; 3% of black …
or NSAIDs between 2008 and 2017 (mean [SD] age, 54 [16] years; 56% female; 3% of black …
Drug stewardship in chronic kidney disease to achieve effective and safe medication use
RK Hall, R Kazancıoğlu, T Thanachayanont… - Nature Reviews …, 2024 - nature.com
People living with chronic kidney disease (CKD) often experience multimorbidity and require
polypharmacy. Kidney dysfunction can also alter the pharmacokinetics and …
polypharmacy. Kidney dysfunction can also alter the pharmacokinetics and …
[HTML][HTML] Frailty modifies the association between opioid use and mortality in chronic kidney disease patients with diabetes: a population-based cohort study
The prevalence of chronic pain in patients with chronic kidney disease (CKD) and diabetes
mellitus is high and correlates with higher frailty risk, but satisfactory pain control frequently …
mellitus is high and correlates with higher frailty risk, but satisfactory pain control frequently …
Non-steroidal anti-inflammatory drugs in chronic kidney disease and risk of acute adverse kidney events according to route of administration
Background Topical non-steroidal anti-inflammatory drugs (NSAIDs) have lower risks for
cardiovascular disease and gastrointestinal adverse effects compared to oral NSAIDs, but …
cardiovascular disease and gastrointestinal adverse effects compared to oral NSAIDs, but …
Two Weeks of Continuous Opioid Treatment in an Adenine-Induced Mouse Model of Chronic Kidney Disease Exacerbates the Bone Inflammatory State and Increases …
Patients with chronic kidney disease (CKD) report high pain levels, but reduced renal
clearance eliminates many analgesic options; therefore, 30–50% of CKD patients have …
clearance eliminates many analgesic options; therefore, 30–50% of CKD patients have …
Nonsteroidal anti-inflammatory drugs in end-stage kidney disease: dangerous or underutilized?
KS Tang, AD Shah - Expert Opinion on Pharmacotherapy, 2021 - Taylor & Francis
Introduction: Nonsteroidal anti-inflammatory drugs (NSAIDs) are a popular class of
analgesic and anti-inflammatory medications, but their use is often avoided in end-stage …
analgesic and anti-inflammatory medications, but their use is often avoided in end-stage …